超10亿元需求清单发布 川渝“医工交叉”项目在成都天府国际生物城签约

Core Insights - The "2025 Chengdu High-tech Zone IVD Industry Supply and Demand Seminar" was held in Chengdu, attracting over 200 participants from leading IVD companies, top academicians, and experts from major hospitals in the Sichuan-Chongqing region, aiming to create a collaborative platform for the IVD industry [1] Group 1: Event Overview - The seminar focused on the theme "Connecting Sichuan and Chongqing, Innovating the Future," aiming to integrate resources across various sectors including government, industry, academia, research, finance, and healthcare [1] - Key activities included policy interpretation, sharing of cutting-edge technologies, supply-demand matching, and project signing, all aimed at fostering high-quality development of the biomedicine industry in the Chengdu-Chongqing economic circle [1] Group 2: Industry Opportunities - Six leading IVD companies from the Sichuan-Chongqing region released an "Opportunity List," covering areas such as IVD reagent R&D, smart manufacturing equipment procurement, and clinical collaborations, with a total value exceeding 10 billion [1] - Collaborative projects were launched between institutions like the Sichuan Academy of Medical Sciences and Chengdu Medical College, focusing on technical challenges and joint talent cultivation [2] Group 3: Collaborative Agreements - Several companies signed "medical-engineering crossover" cooperation agreements, including Chengdu Danodi Medical Technology Co., Ltd. and Chengdu Medical College, focusing on IVD talent training and AI technology development [2] - The event emphasized the integration of AI in IVD, showcasing practical applications in diagnostic reagent development and clinical testing efficiency [2] Group 4: Industry Insights and Discussions - The seminar featured thematic discussions and roundtable forums, addressing topics such as integrated regulatory models for medical device reviews, IVD ecosystem construction from a medical perspective, and international opportunities and challenges [3] - Representatives from various sectors provided insights on regulatory collaboration, industry experience, clinical value, result transformation, financial support, and international pathways for the high-quality development of the Sichuan-Chongqing IVD industry [3]